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RESEARCH ARTICLE
The SDHB Arg230His mutation causing familial paraganglioma
alters glycolysis in a new Caenorhabditis elegans model
Éva Saskői1, Zoltán Hujber2, Gábor Nyıŕő3, István Likó3, Barbara Mátyási1, Gábor Petővári2,
Katalin Mészáros3,4, Attila L. Kovács5, László Patthy6, Shreyas Supekar7, Hao Fan7, Gergely Sváb8,
László Tretter8, Arunabh Sarkar9, Aamir Nazir9, Anna Sebestyén2, Attila Patócs3,4, Anil Mehta10,* and
Krisztina Takács-Vellai1,*,‡
ABSTRACT
The conserved B-subunit of succinate dehydrogenase (SDH)
participates in the tricarboxylic acid cycle (TCA) cycle and
mitochondrial electron transport. The Arg230His mutation in
SDHB causes heritable pheochromocytoma/paraganglioma
(PPGL). In Caenorhabditis elegans, we generated an in vivo
PPGL model (SDHB-1 Arg244His; equivalent to human
Arg230His), which manifests delayed development, shortened
lifespan, attenuated ATP production and reduced mitochondrial
number. Although succinate is elevated in both missense and
null sdhb-1(gk165) mutants, transcriptomic comparison
suggests very different causal mechanisms that are supported
by metabolic analysis, whereby only Arg244His (not null) worms
demonstrate elevated lactate/pyruvate levels, pointing to a
missense-induced, Warburg-like aberrant glycolysis. In silico
predictions of the SDHA-B dimer structure demonstrate that
Arg230His modifies the catalytic cleft despite the latter’s
remoteness from the mutation site. We hypothesize that the
Arg230His SDHB mutation rewires metabolism, reminiscent of
metabolic reprogramming in cancer. Our tractable model
provides a novel tool to investigate the metastatic propensity of
this familial cancer and our approach could illuminate wider SDH
pathology.
This article has an associated First Person interview with the first
author of the paper.
KEYWORDS: Cancer, C. elegans, Familial paraganglioma syndrome,
TCA cycle, Succinate dehydrogenase, Warburg-like glycolysis
INTRODUCTION
Rare cancers challenge biologists because of mechanistic uncertainty
about their origins. Certain subtypes of neuroendocrine cancers
separately described as pheochromocytomas (PHEOs) and
paragangliomas (PGLs) are a case in point. Both are rare, but
share histological and genetic features differing only in anatomical site
of origin: those arising in the adrenal medulla are called
pheochromocytomas, whereas paragangliomas are cancers of the
sympathetic and parasympathetic ganglia of the peripheral nervous
system, with a predeliction for the head and neck region. They are now
regrouped as pheochromocytoma/paraganglioma (PPGL). The annual
PPGL incidence has been estimated at 2-8 per million person per year
(Pacak and Tella, 2000), but, owing to the non-specificity of the
presenting symptoms, which include arterial hypertension, sweating,
headache and tachycardia (Gunawardane and Grossman, 2017), the
condition is almost certainly underdiagnosed (Cascon et al., 2009).
Several mutant genes have been associated with PPGL. These genes
disrupt different signaling pathways (Fig. S1) and can be classified into
three groups: the pseudohypoxia group [including both tricarboxylic
acid cycle (TCA)- and VHL/EPAS1-related genes]; the kinase
signaling group; and the Wnt signaling group. All are complemented
by disease-modifying genes (Kantorovich and Pacak, 2018).
This article focuses on succinate dehydrogenase (SDH), onemember
of the TCA-related subgroup. This enzyme consists of four subunits –
SDHA, SDHB, SDHCand SDHD – encoded by SDHA, SDHB, SDHC
and SDHD genes, respectively. Further components of the TCA-related
subgroup are the SDH assembly factor (SDHAF2) and the enzyme
catalyzing the downstream TCA step, fumarate hydratase (FH). As the
driver of mitochondrial complex II, SDH has a dual function in
mitochondrial energy generation. SDH converts succinate to fumarate
in the TCA cycle, but, en passant, transfers electrons into the electron
transport chain via ubiquinone, by funneling electrons across the
mitochondrial inner membrane towards oxygen as the final acceptor
(Benn et al., 2015). The tetrameric SDH complex is membrane
anchored through the SDHC and SDHD subunits. A hydrophilic
flavoprotein, SDHA, inside this complex hosts the catalytic cleft of the
enzyme and acts in concert with its hydrophilic partner, SDHB.
The SDHB subunit has three highly conserved iron-sulfur clusters
(2Fe-2S, 4Fe-4S, 3Fe-4S) that undergo oxidation-reduction reactions
as electrons pass. The two hydrophobic SDHC and SDHD partners
complete the tetramer and serve as membrane anchors and the
ubiquinone-binding site (Rustin and Rotig, 2002).
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SDH mutations are thought to cause malignant change by three
principal mechanisms. First, the sentinel event is the random allelic
loss of the wild-type allele termed loss of heterozygosity (LOH).
Second, it is believed that in many such cancer-linked SDH
mutations (now renamed SDHx), mitochondrial succinate
accumulates. This TCA intermediate can both modify proteins
post-translationally and act as a signaling molecule (Murphy and
O’Neill, 2018) that is released into the cytoplasm, where it can
competitively inhibit oxygen-sensing prolyl hydroxylases (PHDs)
(Lin et al., 2012). Following inhibition of PHD, HIF1α is not
labeled for proteasomal degradation and active HIF favors
pseudohypoxia-driven tumorigenesis through mal-activation of
hypoxia-responsive genes such as vascular endothelial growth
factor (VEGF; also known as VEGFA) or glucose transporter 1
(GLUT1; also known as SLC2A1) (Pollard et al., 2005; Selak et al.,
2005). Third, it is suggested that dysfunctional SDHx can trigger
increased levels of reactive oxygen species (ROS) with potential to
damage macromolecules including DNA, proteins and lipids (Slane
et al., 2006; Guzy et al., 2008; Tretter et al., 2016). The net result is
suggested to promote tumorigenesis, but many uncertainties exist
and the mechanisms have not been fully clarified.
It is curious that SDHA, SDHC and SDHD mutations typically
cause benign tumors, whereas mutations in the gene encoding
subunit B are, for unknown reasons, strongly associated with high
metastatic potential. Additionally, significant numbers of SDHB-
affected patients harbor germ line SDHB mutations and suffer from
a particularly aggressive form of malignant PPGL (Amar et al.,
2005; Timmers et al., 2007), whereas other family members with
identical SDH mutations remain free of metastatic disease (see
modifier genes above and mev-1 below). The mechanisms are
obscure. We hypothesized that a critical advance would be the
establishment of a tractable animal model of an aggressive germ line
form of SDHB mutation (see below). Hence, we analyzed the
biological functions of the highly conserved SDHB homolog sdhb-1
in the nematode Caenorhabditis elegans.
An extensive characterization of parts of the SDHx complex has
already been performed in this nematode. The role of the SDHC
ortholog mev-1 is particularly well studied in response to oxidative
stress (Senoo-Matsuda et al., 2001). However, little is known about
worm SDHB. The C. elegans succinate dehydrogenase B homolog
sdhb-1 gene was first analyzed by Huang and Lemire (2009), who
found awell-conserved proline residue close to the proximal quinone-
binding site (Qp).When this Pro211wasmutated, which corresponds
to Pro197 in the human SDHB protein, SDH assembly and function
were impaired, leading to increased superoxide anion production and
perturbed mitochondrial respiration (Huang and Lemire, 2009).
Our interest in SDHx was prompted by a family with an
Arg230His missense SDHBmutation that leads to a familial form of
malignant PHEO. This mutation has a variable penetrance estimated
to be less than 50% (Hes et al., 2010). The disease first appeared in
this family as a classical PHEO in the mother (see Fig. 1B for family
tree), who was diagnosed in her second decade. After her death in
her 50s from metastatic disease, other family members were
sequenced. It was found that her non-identical twin children (twins
amongst four siblings) and her own adult brother also carried
Arg230His. The brother, now in his 70s, remains tumor free.
Fig. 1. Conservation of SDHB and its mutation in heritable cancer. (A) Clustal W multiple alignment shows that C. elegans SDHB-1 has 60% identity
and 84% similarity to the human homolog (identical or similar residues highlighted in blue and light blue, respectively). Three cysteine motifs characteristic of
conserved iron-sulfur clusters are underlined. The boxed area and arrow indicate the critical Arg230 position. (B) Pedigree carrying mutated Arg230His SDHB,
the mutation that can lead to pheochromocytoma/paraganglioma. Individual I.4 died of disseminated malignancy. Individuals I.2 (age 70) and I.3 (age 74)
are tumor free; II.6 and II.7 (both 39, non-identical twins) each have tumors. (C) Genomic structure of the sdhb-1 region and gk165 deletion (dashed red lines
indicate the deleted 2198 bp, including the first five exons of sdhb-1 and the first and partially the second exon of the neighboring gene, cup-15). We also analyzed
a transgenic strain (see Results) containing a missense mutation G1647A in the genomic sequence (G731A in the cDNA) resulting in Arg244His.
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The Arg230His mutation in this family corresponds to the
C. elegans Arg244His SDHB-1 mutation. For readers unfamiliar
with worm biology, please see Fig. S2 for the worm life cycle. First,
we built nematode models of this SDHBmutation, wherewe used an
existing sdhb-1(gk165) deletional worm and then generated two
transgenic lines carrying either the above Arg244His mutation or its
genomic wild-type SDHB as a control. Unexpectedly, our results
showed that although fully deletional ‘null’ mutants arrest
development soon after egg hatching at the L2 larval stage, the
missense Arg244His point mutants develop much further, to the last
larval L4 stage, but thereafter can only generate sterile adults. Next,
we analyzed the metabolic profile of the mutants using
complementary metabolic and genetic approaches, finding that
Arg244His mutant animals are metabolically very different from
their SDHB-null counterparts in a manner that cannot be explained
simply by their differential timing of developmental arrest. The
missense mutants (but not the null mutants) display aberrant
glycolytic activity, principally manifesting as highly elevated lactate
and pyruvate levels. Finally, bioinformatics analysis, alongside
models of the SDH structure, led us to propose a pathway disorder
following this missense mutation. The combined data suggest the
existence of a missense-mutation-dependent, rewired form of
metabolism reminiscent of the Warburg effect metabolic
reprogramming that is characteristic of tumor cells. Our animal
model not only provides insight into a heritable SDH impairment,
but also creates a useful tool that might help to not only decipher the
enigmatic nature of other SDHx-associated pathologies, but also
shed light on the genesis of aberrant glycolysis following just one
missense mutation within complex II of mitochondria.
RESULTS
Generation and characterization of worms carrying the
SDHB Arg244His mutation
The C. elegans genome encodes a well-conserved homolog of
SDHB, sdhb-1 (F42A8.2), located on chromosome II. This SDHB-1
protein shows 60% sequence identity and 84% overall similarity to
its human counterpart (Huang and Lemire, 2009) (Fig. 1A). Of note,
100% identity exists around the iron-sulphur (FeS) clusters that
mediate electron transfer (Fig. 1A, underlined). In order to better
understand the consequences of the familial p.Arg230His (SDHB
c.689G>A), we generated the corresponding mutation, Arg244His
(G731A in the cDNA) in the worm (Knudra Transgenics, Murray,
UT, USA). We created two transgenic lines by inserting either the
wild-type or G731A point mutant construct in single copy (at awell-
defined neutral locus on the X chromosome) using transposon-
mediated gene insertion (MosSCI). We made the following worm
lines: COP957 [pNU637 (sdhb-1p::sdhb-1(genomic wild-type)::
sdhb-1 3′UTR; unc-119(+)) X.; unc-119(ed3) III.] and COP952
[pNU636 (sdhb-1p::sdhb-1(G731A)::sdhb-1 3′UTR; unc-119(+))
X.; unc-119(ed3) III.]. These transgenic strains each contain two
corresponding transgenic sdhb-1 copies on their X chromosomes in
addition to their endogenous copies on chromosome II.
To create animals carrying only two transgenic wild-type or
only two G731A point mutant copies, COP957 and COP952
strains were crossed into the sdhb-1(gk165) null background.
This deletion removes all or part of exons 1-5 of sdhb-1 (Fig. 1C)
and induces L2 larval lethality in a homozygous form (strain
VC294, also known as LB713, see Huang and Lemire, 2009).
This sdhb-1(gk165) strain can be maintained as a balanced
heterozygote using the GFP-labeled balancer mIn1mIs14.
Balancer mIn1 is an inversion in the center of chromosome II,
including sdhb-1, and carrying mIs14, which is an integrated
[myo-2::gfp; pes-10::gfp] transgene (glowing in the pharynx of
larvae and in embryos).
First, we crossed wild-type (COP957) and G731A point mutant
(COP952) transgenic lines into sdhb-1(gk165) null mutant
background and determined whether these transgenes were able to
rescue the deletion caused by gk165. As a validation of our method,
and using over 200 worms, we first observed that only the wild-type
transgene could complement the deletion [rescue in 97% of worms,
which we will refer to hereafter as wild type rescued (WTR);
Fig. 2A; Fig. S3)]. In contrast, the G731A rescue generated sterile
adults with a protruding vulva (the ‘Pvl’ phenotype; Fig. S3); these
phenotypes were not further analyzed. Henceforth, we refer to the
G731A point mutant animals on a deletional background as R244H
(Arg244His) (Fig. 2A; Fig. S3). To facilitate propagation, the
R244H animals were also balanced using mIn1mIs14, as for gk165
deletional mutants.
Next, we compared the lifespan of homozygous sdhb-1(gk165)
mutants against wild-type worms and observed that gk165
homozygotes survived about half as long as wild-type control N2
(WT) animals (Fig. 2B; Table S1), consistent with the data of Pujol
et al. (2013), who found that sdhb-1-specific RNA interference
(RNAi) treatment also resulted in a similarly shortened lifespan.
R244H worms also showed a shortened lifespan compared to WT
andWTR animals (Fig. 2B; Table S1). In addition, we examined the
effect of the above mutations on development. At 20°C on day 3
after hatching, WTR generated viable adults similar to WT worms,
whereas sdhb-1(gk165) animals showed arrested development at
L2, as expected. In contrast, R244H worms reached adulthood on
only day 4-5, indicating delayed development (Fig. 2C).
In order to investigate the proteins generated by the gk165 and
Arg244His sdhb-1 mutant alleles, we performed Western capillary
immunoassay (Wes) experiments using a human SDHB-specific
antibody, which successfully cross-reacted with the worm SDHB-1
protein, likely due to the high level of conservation. As expected,
gk165 represents a null allele as no antibody specific band can be
detected, whereas the same antibody recognized a single, well-
defined band of 32 kDa, specific for SDHB-1 in all control samples
(Fig. 2D). In R244H mutants, the point mutant protein is also
detectable, but present in a lower quantity (Fig. 2D).
Transcriptomics data verify Wes results at the mRNA level: we
find that sdhb-1 mRNA lies below the detectable limit in gk165
mutants, whereas in R244H point mutants, sdhb-1 mRNA is
transcribed, although at a decreased level (Fig. 2E; Table S8).
In addition, we generated a psdhb-1::gfp strain carrying an
extrachromosomal array of a transcriptional reporter construct and
analyzed its expression pattern. We found that the transgene begins
to be expressed from the comma stage during embryogenesis
(Fig. 3A,A′) and persists throughout larval stages (Fig. 3B-E) into
adulthood (Fig. 3F). SDHB-1 is expressed in the pharynx (Fig. 3D),
intestinal (Fig. 3D) and hypodermal (Fig. 3E) cells, head and tail
neurons (Fig. 3F), and in the ventral nerve cord (Fig. 3F).
Metabolic characterization of sdhb-1 deletional and SDHB
Arg244His point mutants shows elevated succinate-to-fumarate
ratios and attenuated oxygen consumption with reduced
mitochondrial and ATP content. Deficiency of SDH impairs the
conversion of succinate to fumarate, thereby disrupting the TCA
cycle (Fig. 4A). Therefore, we compared TCA-related metabolite
levels, glycolytic activity and the efficiency of stimulated
mitochondrial oxygen consumption in sdhb-1(gk165) null
mutants, R244H point mutants, WTR worms (which served as
comparators for point mutants) and wild-type L2, L3 and L4 larvae
as further stage-dependent controls.
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Metabolite concentrations (succinate, fumarate, malate, citrate,
glutamate, alpha-ketoglutarate, aspartate, pyruvate and lactate) were
measured by liquid chromatography–mass spectrometry (LC-MS)
(Fig. 4B; Table S2) using methods described earlier (Hujber et al.,
2018), but adapted herein, as follows. In preliminary experiments,
extracts from multiple independent worm batches determined the
lower limit of detection of the above metabolites (five independent
batches; data not shown). Next, individual worms of a given
genotype and larval stage were picked manually. Finally, worm
number was normalized to a common cell number to compare
metabolite data from different genotypes, shown as pmol/million
cells (Fig. 4B; Table S2).
Citrate and malate levels were similar across strains, providing a
ready reference measurement when different metabolites were
compared in the examined genotypes. The succinate precursor,
alpha-ketoglutarate (aKG), level was always below the detection
limit, irrespective of genotype. The SDHB product, fumarate, was
present in small quantities. As expected, succinate was elevated in
the sdhb-1(gk165) deletional mutant, but, interestingly, R244H
point mutants also showed an equivalent succinate rise (Fig. 4B;
Table S2). The succinate-to-fumarate ratio was similarly elevated in
both mutants despite their different developmental stages (Fig. 4C).
These data pointed to a complex metabolic phenotype dependent on
the mutation status of SDHB. For example, both aspartate and
glutamate levels were decreased in R244H point mutants compared
to wild-type and transgenic WTR L4 animals (Fig. 4B; Table S2).
Furthermore, R244H point mutants (but not null mutants) displayed
significantly higher pyruvate and lactate levels compared to their
larval stage-matched L4 controls (Fig. 4D; Table S3).
Because the SDH complex plays a parallel role in complex II of
the mitochondrial respiratory chain (see Introduction), we next
determined the stimulated mitochondrial oxygen consumption rate
(OCR) using the Seahorse technique in the above sdhb-1 deletional
worms, point mutants and control strains.
Fig. 2. Phenotypic analysis of nematodes carrying either null allele gk165 or G731A missense mutation in the sdhb-1 gene. (A) Complementation of
gk165 null deletion by the wild-type transgene [wild type-rescued (WTR) animals, light-blue bar] led to fertile adults in 97% of the WTR cases (n=168)
relative to wild type (WT, black bar), whereas R244H worms that reached adulthood (n=83) were devoid of reproductive progeny; sdhb-1(gk165)mutants do not
progress beyond L2. (B) Lifespan of deletional and point mutant animals was measured against that of the corresponding controls. sdhb-1(gk165) (n=125)
mutants and R244H (n=166) transgenic animals showed a significantly shorter survival compared to their respective controlsWT (n=241) andWTR (n=100) (n=3
separate experiments). (C) At 20°C, on day 3 after hatching, WT and WTR worms grew into fertile adults, while R244H animals reached adulthood only on
day 4-5, suggestive of delayed development. The sdhb-1(gk165) animals showed arrested development at the L2 larval stage. (D)Wes experiment shows that the
32 kDa band specific for SDHB-1 is absent in gk165 null mutants, but is present in all control strains (WT and WTR). R244H animals also express SDHB-1
[relative to DYN-1 (93 kDa) loading control]. (E) RNA-seq data related to sdhb-1 also verify Wes results: sdhb-1message is present in all examined strains except
gk165 null mutants, for which the sdhb-1-specific mRNA lies below the detectable limit. RPKM, reads per kilobase per million mapped reads. The black horizontal
line represents a threshold, below which no functional protein is observed. Statistical significance is indicated in each graph as ***P≤0.001 and **P≤0.01
versus the corresponding sample (NS, not significant; independent two-sample Student’s t-test with Bonferroni correction). Error bars represent s.e.
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The Seahorse XF96Metabolic Analyzer has previously been used
in whole organisms such as C. elegans (Luz et al., 2015; Koopman
et al., 2016). We used this device to study the action of two
mitochondrially active compounds, protonophore carbonyl cyanide
p-(trifluoromethoxy) phenylhydrazone (FCCP) and the complex IV
(cytochrome oxidase) inhibitor sodium azide, to assess stimulated
bioenergetics in sdhb-1mutant worms and control strains (Fig. 4E,F).
There were no differences in either the unstimulated, basal OCR or
the OCR following sodium azide addition between the mutants and
control animals. The addition of protonophore FCCP resulted in
elevated, maximal oxygen consumption in all control animals. In
marked contrast, in gk165 deletional and R244H mutants, oxygen
consumptionwas unchanged after FCCP injection, implying a loss of
reserve capacity of respiration in these mutants (Fig. 4E,F; Table S4).
As the SDH complex is an integral part of complex II of the
mitochondrial electron transport system and its deficiency may
hamper mitochondrial integrity and hence energy production, we
next estimated the functional mitochondrial content using
Mitotracker dye, the uptake of which is dependent on
mitochondrial transmembrane potential and measured total ATP
production, using a bioluminescent ATP assay. We observed that
deletional as well as point mutants of sdhb-1 had not only
significantly fewer healthy mitochondria but also demonstrated
downregulated ATP production, compared to wild-type and
rescued strains (Fig. 5; Tables S5 and S6).
Possible impact of the Arg244His mutation on the molecular
structure of SDHB-1 in C. elegans
The Arg244His mutation of C. elegans SDHB-1 corresponds to the
Arg230His mutation of human SDHB, which leads to a familial
form of malignant PPGL (Brouwers et al., 2006; Cerecer-Gil et al.,
2010). We hypothesized, from the conservation of residues around
this site (indicated by the boxed area and arrow in Fig. 1A), that
Arg230 plays an equivalent role across the SDHBs of these distant
species. In the X-ray structure (PDBID 4YTP) of the SDHB subunit
of porcine heart (Inaoka et al., 2015), the guanidino group of Arg230
of SDHB forms two hydrogen bonds with the carboxyl oxygens of
the side chain of Asp224. In addition, Arg230 is hydrogen bonded
with the peptide backbone atoms of residues Glu154, Tyr156 and
Phe226. The structural importance of the Asp224-Arg230 salt bridge
is supported by the observation that both residues are conserved from
bacteria to mammals (Fig. 6A). Hence, substitution of Arg230 by
other residues, such as His, Cys, Gly and Leu (Cerecer-Gil et al.,
2010), is likely to disrupt the strong hydrogen bonding between
residues 224 and 230, which might impair protein function (see
Discussion). In order to probe the effect of R230Hmutation in human
SDHB, we constructed homology models of the human SDHA/B
complex for the wild type and R230H mutant, based on the above
structure of the porcine SDHB subunit (Fig. 6B). To evaluate the
structural changes induced by themutation, we calculated all pairwise
residue contacts for the 20 top-scoring wild-type and mutant models.
The difference in averaged pairwise contacts from wild type to
R230H mutant indicates a reduction of about five inter-residue
contacts upon the mutation (Fig. 6C,D; see also Table S7 and Fig. S4
for a detailed description and a network representation of the
sidechain perturbations seen in the models as a result of mutation).
Although the most prominent perturbations are close to the mutation
site, we also find an appreciable loss of contacts at the interface
between the distant N-terminal domain of SDHB (∼30 Å away from
the mutation site) and SDHA (Fig. 6D; Fig. S4). The structural
models suggest that the reduction of inter-residue contacts, alongwith
disruption of the SDHA-SDHB interface, might render the complex
inactive or, alternatively, result in aberrant SDH activity after the
distal R230H mutation.
Fig. 3. SDHB-1 is ubiquitously expressed throughout worm development. (A,A′) A transcriptional reporter construct shows strong expression of SDHB-1 in
embryos in the comma stage (A, lateral view; A′, ventral view). (B-F) SDHB-1 expression persists throughout larval stages (B, L1; C, L2; D, L3; E, L4) into
adulthood (F) with intense expression in the pharynx (D, arrowhead), together with intestinal (D, arrow) and hypodermal (E, arrowhead) cells, head and tail
neurons (F, arrowheads) and the ventral nerve cord (F, arrows). In all panels, anterior is to the left and dorsal is up. These panels are composites.
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Transcriptomic analysis reveals a metabolic shift towards
glycolytic activity in Arg244His point mutants
We used a transcriptomic analysis of RNA extracted from deletional
and point mutants versus stage-specific controls to better understand
our observed phenotypic differences. We found that expression of
genes encoding vitellogenins (such as vit-2, vit-5, vit-6) and genes
required to build the cuticle (for example, col-140, col-122, col-123
or bli-6) were increased in the point mutant worms, consistent with
their later developmental arrest point (point mutants develop to
adulthood whereas null mutants arrest at L2). We observed that
Fig. 4. See next page for legend.
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R244H point mutants also show a decreased expression of
germline-specific genes (gld-1 or spch-1) when compared to
wild-type worms, which might relate to the sterility of R244H
animals. Interestingly, given the neurological nature of the disease,
in deletional mutants, some genes associated with the nervous
system (for example, C06B3.6, B0205.13, F18E3.12, F09F7.6) are
highly overexpressed, which requires further study (data not
shown).
Next, we focused on genes related to the observed differences in
the metabolic profiles of sdhb-1 deletional and point mutants
(Fig. 7A-C). Because our LC-MS data revealed a differentially
compromised TCA cycle in sdhb-1 null compared to point mutants
(e.g. elevated succinate-to-fumarate ratio in both mutant
backgrounds but a selective accumulation of pyruvate and lactate
in point mutants), we first selected genes encoding TCA cycle-
related enzymes and enzymes regulating lactate and pyruvate levels
(Fig. 8A,B labeled in blue). First, we compared their expression
levels in the null sdhb-1(gk165) and R244H mutants versus their
stage-specific control strains (Fig. 7A,B). We observed an
overlapping gene expression profile between the null and point
mutants compared to their respective stage-matched controls.
Specifically, we identified differences in the expression of
aconitase (aco-2), isocitrate dehydrogenase (idh-2), isocitrate
lyase/malate synthase of the glyoxylate cycle (icl-1), fumarase
( fum-1), pyruvate carboxylase ( pyc-1), phosphoenolpyruvate
kinase ( pck-1/2) and lactate dehydrogenase (ldh-1) compared to
the appropriate stage-matched controls. In some instances, both
mutants showed increased icl-1, aco-2 and pyc-1 pck-1/2
expression, whereas only null mutants showed decreased fum-1
expression. The fum-1 gene product controls the immediate fate of
succinate as it is generated in the TCA cycle. Conversely, only the
point mutants displayed elevated ldh-1 levels compared to stage-
matched L4 controls. This is consistent with our metabolic data
(Fig. 7A,B) showing selective lactate accumulation in the point
mutant.
Next, we used real-time quantitative PCR (qPCR) to validate
expression levels of the above mentioned genes using cdc-42 as a
reference gene (Hoogewijs et al., 2008): expression levels were
normalized to this gene using the ddCt method (Pfaffl, 2004). Genes
were grouped by low, moderate and high expression relative to our
transcriptomic analysis. In deletional mutants, the relatively lowly
expressed genes included sdha-1 and fum-1; the moderately
expressed genes included glutamate dehydrogenase (gdh-1)
and malic enzyme (men-1). In point mutants, highly selectively
elevated expressed genes included idh-2 and ldh-1, compared to
aco-2, icl-1, pyc-1 and pck-1/2, which were increased in both
mutants (Fig. 7A,B; Table S8).
qPCR measurements largely confirmed previous transcriptomic
data. Expression of icl-1, the bifunctional key enzyme of the
glyoxylate shunt, showed the most remarkable change in both
deletional and point mutants compared to the appropriate controls
(∼20-fold or 10-fold change in deletional and point mutants,
respectively; Fig. 7C; Table S9). qPCR data also confirmed results
found in metabolic analysis: ldh-1, which generates lactate from
pyruvate, was strongly and selectively increased in point mutant
animals (Fig. 8A,B; Table S9). Interestingly, only R244H mutants
showed increased aco-2, idh-2, sdha-1, fum-1 and mdh-2
expression. Both mutants showed elevated pck-2 and pyc-1
expression, which code for key enzymes of gluconeogenesis
(Fig. 8A,B; Table S9).
Effects of icl-1(RNAi) and a lactate dehydrogenase inhibitor
on sdhb-1 mutants
Next, we undertook some pilot experiments to determine whether
our model is drug responsive. Based on our metabolomic data, the
glyoxylate cycle plays an important role in the metabolism of sdhb-
1 mutants as we found that isocitrate lyase (icl-1) expression was
significantly elevated in both mutant backgrounds (Fig. 7 and
Fig. 8A,B). We first attempted to attenuate the glyoxylate shunt by
silencing ICL-1 activity by feeding sdhb-1 mutants with HT115
bacteria expressing double-stranded RNA (dsRNA) specific for
icl-1 [icl-1(RNAi)]. This influenced the lifespan and viability of
sdhb-1(-) null mutants as follows: icl-1(RNAi) treatment resulted in
partially penetrant lethality of gk165 mutant embryos (Fig. 8C;
Table S10) such that 42.5% of gk165 animals treated with
icl-1(RNAi) died as embryos, about double the controls (19.9%,
fed with bacteria expressing the empty vector). Furthermore, gk165
null mutants exposed to dsRNA specific for icl-1 had significantly
shorter lives compared to controls (Fig. 8D; Table S1). Interestingly,
neither the lifespan nor the viability of R244H point mutants was
affected by icl-1(RNAi) (Fig. 8C,D).
As point mutants showed a significant increase in lactate
dehydrogenase (ldh-1) expression, we applied an inhibitor that
targets the human LDH-1 homolog lactate dehydrogenase A
(GSK2837808A) and is known to inhibit tumorigenesis in mouse
models (Xie et al., 2014). GSK2837808A arrested the development
of R244H point mutants at an earlier time point, such that R244H
mutant embryos grown on bacteria and the LDH-A inhibitor at
10 µM concentration arrested development at the L2/L3 larval stage
in 12.4% of cases, whereas the untreated controls reached adulthood
but remained sterile (Fig. 8E; Table S11).
DISCUSSION
In this work, our first aim was to create a tractable in vivo model of
the SDH/complex II in the mitochondrial respiratory chain that
catalyzes the oxidation of succinate to fumarate pari passu with the
reduction of ubiquinone to ubiquinol. SDH is difficult to study
because it has four subunits, encoded by separate genes (SDHA-D)
that work in concert to link the TCA cycle to electron transport.
Our second aim was to determine whether a worm model
would enable a better understanding of the different biological
Fig. 4. TCA cycle and related metabolites in sdhb-1 null and R244H point
mutant worms and their effects on oxygen consumption. (A) TCA cycle
and related metabolites: metabolites (blue) were analyzed by LC-MS in WT L2
(n=2300), L3 (n=2000), L4 (n=1750) larvae, sdhb-1(gk165) null mutants
(n=2300), WTR (n=1750) and R244H point mutant (n=1750) animals.
(B) Results from n=6 separate experiments measuring citrate (CIT), succinate
(SUC), fumarate (FUM), malate (MAL), pyruvate (PYR), lactate (LAC) and
glutamate (GLU) in deletional mutants and their developmental-stage control
L2 and L3 WT animals (charts in red, dark green and light green, respectively)
or in R244H mutants and their control L4 WTR and WT animals (charts in dark
blue, black and light blue, respectively). Aspartate (ASP) was detected only in
L4 WT and WTR animals (undetectable in L4 R244H point mutants).
Alpha-ketoglutarate levels were undetectable in all (not shown). (C) The
succinate-to-fumarate ratio was increased equivalently in deletional and point
mutants. (D) Themetabolic profile of the R244Hmutant differed from that of the
controls. Lactate-to-citrate and pyruvate-to-citrate ratios were calculated based
on similar citrate levels in each worm type. (E,F) The effect of the deletion
versus point mutation on the oxygen consumption (OCR) by Seahorse
technique (n=8 parallel experiments). (E) In the case of sdhb-1(gk165)
mutants (n=800), oxygen consumption was not increased after FCCP
treatment compared to wild-type control. (F) R244H point mutants (n=260)
failed to show accelerated oxygen consumption in response to FCCP, as also
seen in the null worms. Statistical significance is indicated in each graph as
***P≤0.001 versus the corresponding sample (NS, not significant; one-way
ANOVA). Error bars represent s.e.
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backgrounds following different sdhb mutations, only some of
which are associated with an increased risk of malignant
PPGL. Such a model may be of importance because current
PPGL treatment options are limited. To that end, using
bioinformatic tools, we also explored the structural
consequences of one SDHB missense mutation that might
affect the SDHA-SDHB interface.
Amongst SDHB mutations (Burnichon et al., 2009), we focused
on worms bearing the Arg230His missense mutation that is causal of
a familial form of PPGL. We generated two transgenic lines carrying
the Arg244His missense mutation (corresponding to human
Arg230His) and genomic wild-type sdhb-1. These transgenic lines
were crossed into the sdhb-1(gk165) deletional background. As
expected, only the wild-type SDHB transgene efficiently rescued the
L2 larval arrest that is characteristic of the SDHB null mutant. In
contrast, the point mutant corresponding to human Arg230His was
unable to fully complement the deletional phenotype, producing only
sterile adults with a significantly shortened lifespan of a similar
degree to that of null mutants. These data are consistent with known
lifespan-shortening effects of mutations in the C. elegans SDHC
mev-1 subunit (Chang et al., 2017).
To gain more insight into the nature of gk165 and Arg244His
mutant alleles, we examined whether SDHB is transcribed and
translated in these mutant backgrounds. Wes was used to determine
SDHB-1 status by applying a human anti-SDHB antibody, which
successfully cross-reacted with the homologous worm protein. We
first confirmed that gk165 represents a true null allele as in this
background SDHB-1 protein is absent. In Arg244His mutants,
SDHB-1 is transcribed and translated, but at a lower level compared
to the wild-type control. This result shows that the SDHB-1 R244H
protein is stable enough to be detected, although it is functionally
defective in the TCA cycle, given the elevated succinate-to-furmarate
ratio. However, we do not know whether the SDH complex stays
intact in the mutant or whether soluble SDHA is released with an
attenuated function described as ‘CII low activity’ (Bezawork-Geleta
et al., 2018). The status of SDHA needs to be examined in both
sdhb-1 deletional and point mutants in future studies.
In our metabolic studies, the gk165 null allele showed the
expected elevation of the SDH substrate succinate accompanied by a
low fumarate level. Interestingly, point mutants showed an almost
identically elevated succinate-to-fumarate ratio compared to
deletional mutants, suggesting that point mutation also leads to
Fig. 5. sdhb-1mutants show reduced ATP production and functional mitochondrial content. (A) Confocal microscope images (40×) showing comparative
mitochondrial accumulation of Mitotracker Red CMX Ros dye showing reduced fluorescence in gk165 null mutants and R244H point mutants versus
respective rescue or control strains. (B) Relative fold change of the mitochondrial content in the above mutants versus stage-specific controls (n=10). (C) ATP
content analyzed by ATP Bioluminescent Assay (n=2000) as relative light units (RLU). Statistical significance is indicated in each graph as ***P≤0.001,
**P≤0.01 and *P≤0.05 versus the corresponding sample (independent two-sample Student’s t-tests with Bonferroni correction). Error bars represent s.e.
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loss of SDH activity in the TCA cycle. However, the mechanisms
may be very different. Transcriptionally, only the null mutant
displayed a reduction in both the SDHA and fumarase mRNA
levels. Clearly, in the null state, elevated succinate cannot be
further metabolized in the TCA cycle, but we saw no corresponding
reduction in SDHA mRNA in the point mutant worm. Stimulated
oxygen consumption was also equivalently reduced in both
deletional and point mutant animals and was accompanied by
downregulated mitochondrial and total ATP content,
consistent with the notion that this related manifestation of SDH
activity was eliminated equally in both mutants. These results are in
line with published human data (Burnichon et al., 2009) and our
bioinformatic predictions suggesting that the Arg244His
substitution induces a conformational change in the structure of
SDHB-1 that might result in either an inactive or altered enzyme.
Although it is recognized that proteins are fairly robust and point
mutations are unlikely to alter their 3D structure and function
(Bowie et al., 1990), there are accumulating reports of several
systems in which mutation of distal residues can lead to dramatic
changes at a remote active site (Lee and Goodey, 2011), which often
leads to aberrant and even inactive enzymes. Importantly, the
guanidino group of Arg230 (Arg244 in worms) normally forms a
conserved Asp224-Arg230 salt bridge that might be critical for the
stability of SDHB proteins. The importance of this salt bridge is also
supported by the fact that not only the Arg230His mutation
described in this work, but also missense mutation of the bridging
partner’s histidine Asp224His, is linked to hereditary PPGL
(Lefebvre et al., 2012).
Fig. 6. The effect of the Arg230His point mutation in the SDHB subunit on the structure and function of the SDHA/B enzyme complex. (A) Sequence
alignment of SDHB sequences. Asp224 and Arg230, which form a salt bridge in porcine SDHB, are highly conserved, and marked in the alignment in blue and
red, respectively. The positions of residues Glu154, Tyr156 and Phe226, the peptide backbone atoms of which also form hydrogen bonds with Arg230,
are marked in green in the alignment. (B) Superimposition of the top-scoring wild-type (blue) and R230H (red) human SDHA/B homology models to porcine
SDHA/B X-ray structure (PDB ID 4YTP; shown in white). Co-factors are shown in sphere representation, while residues 224 and 230 of SDHB are
shown in stick representation for the wild-type and mutant models in blue and red, respectively. (C) Differences in averaged residue-pair contact
frequencies from the 20 top-scoring models. This plot illustrates residue pairs that exhibit a loss (positive) or gain (negative) of contacts in more than 40%
(>8 out of the 20 models) going from wild-type to the R230H mutant. (D) Structural annotation of the major contact changes in SDHA/B complex
upon R230Hmutation as seen in C (>40%). The beads in the inter-residue space indicate the location and the extent of structural perturbation. The extent of
perturbation upon mutation is color coded in RWB space [R=1; W=0; B=–1], with red indicating loss of contact and blue indicating formation of a new
contact. Highest perturbation is seen near the mutation site (see solid red line inset), but a significant loss of contacts is also observed at the interface of
SDHA and SDHB (see dotted red line inset). FeS, iron-sulphur; FMN, flavin mononucleotide.
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Despite the above similarities in bioenergetics, the null and point
mutants show significant developmental differences: the null worms
show arrested development at the L2 larval stage, whereas point
mutants develop further, eventually reaching adulthood, although
they are then sterile. In order to understand this discrepancy, we
carried out a relative metabolic and transcriptomic analysis of the two
mutants.
We found elevated isocitrate lyase (icl-1) expression in both
mutants (confirmed by qPCR, below). Isocitrate lyase is the key
enzyme of the glyoxylate shunt, which cleaves the TCA
intermediate isocitrate to generate the two products, glyoxylate
and succinate. In the glyoxylate shunt, malate synthase then
converts glyoxylate and acetyl-CoA into malate (Fig. 8A,B). The
glyoxylate shunt is a variation of the TCA cycle, which centers on
the conversion of acetyl-CoA to succinate, thereby enabling the
synthesis of carbohydrates. This action transects the TCA by
bypassing the steps that normally liberate carbon dioxide as aKG
catabolized to succinate. The glyoxylate shunt functions in plants,
some microorganisms and nematodes, but it remains controversial
as to whether it can function in humans (Strittmatter et al., 2014). In
wild-type worms, the glyoxylate cycle is active during early
development (at the pre-hatching embryonic development and at the
first L1 larval stages), peaks at L2, and then declines thereafter in
L3-L4 larvae through to adulthood (Liu et al., 1997). Energy
production through the TCA cycle shows an opposite tendency as its
activity is elevated after hatching and increases substantially
throughout L1-L4 larval development (Wadsworth and Riddle,
1989). The metabolic switch between the (early) glyoxylate shunt
and the (later) TCA cycle pivots at the L2/L3 larval stage, exactly
when we observed arrested development in sdhb-1(gk165)
deletional mutants.
Correspondingly, transcriptomic and qPCR data showed elevated
icl-1 expression in deletional mutants, which arrest at L2 larval
stage, in which the glyoxylate cycle is active. icl-1 expression was
also increased in Arg244His point mutants, which might
compensate for the absence of SDH activity in the TCA cycle.
Fig. 7. Transcriptomic analysis of sdhb-1(gk165) deletional and Arg244His point mutants reveals different metabolic alterations. (A,B) Transcriptomic
analysis in sdhb-1(gk165) deletional mutants (n=5000) (A) and R244H (Arg244His) point mutants (n=2500) (B), relative to their wild-type stage controls.
(C) qPCR experiments performed for a subset of genes analyzed by transcriptomics in sdhb-1(gk165) deletional and R244H (Arg244His) point mutants. In A-C,
dark-green and light-green columns show the ratio of mutant expression versus WT L2 (n=5000) and L3 (n=5000) controls, respectively. Black and blue columns
show the ratio of mutant expression versus WT L4 (n=2500) and WTR L4 (n=2500) controls, respectively. The genes analyzed are indicated in the x-axes;
fold change is represented in the y-axes. Underexpressed genes have values between 0 and 1; overexpressed genes have values from 1 upwards. Genes
encoding the following enzymes were analyzed: CTS-1, citrate synthase; ACO-2, aconitase; IDH-1/2, isocitrate dehydrogenase; OGDH-1, oxoglutarate
dehydrogenase; SUCA-1, succinyl-CoA ligase (ATP-specific) beta subunit; SUCG-1, succinyl-CoA ligase (GTP-specific) beta subunit; SUCL-1/2, succinyl-CoA
ligase (ATP/GTP-specific) alpha subunit; SDHA-1, succinate dehydrogenase A subunit; SDHB-1, succinate dehydrogenase B subunit; MEV-1, succinate
dehydrogenase C subunit; SDHD-1, succinate dehydrogenase D subunit; FUM-1, fumarase; MDH-1/2, malate dehydrogenase; ICL-1, isocitrate lyase/malate
dehydrogenase; PYK-1, pyruvate kinase; PDHA-1, pyruvate dehydrogenase alpha subunit; PDHB-1, pyruvate dehydrogenase beta subunit; PCK-1/2,
phosphoenolpyruvate carboxykinase; PYC-1, pyruvate carboxylase; MEN-1, malic enzyme; LDH-1, lactate dehydrogenase; GDH-1, glutamate dehydrogenase;
GOT-2.2, glutamate oxoacetate transaminase.
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Interestingly, key enzymes of gluconeogenesis ( pck-2, pyc-1) were
not significantly different when point mutants were compared to the
null state. Neither was the relative expression of the message for
several TCA cycle enzymes (ogdh-1, suca-1, fum-1 and mdh-2)
different in R244H worms compared to wild-type controls, which
suggests that the point mutants can express key components of the
TCA cycle in addition to the glyoxylate cycle.
Conversely, gene expression studies showed important
differences in the metabolism of null versus point mutant
worms. Transcriptomics also demonstrated significant metabolic
alterations, consistent with LC-MS measurements in the point and
deletional mutants. Increased expression of the message for the
enzyme interconverting lactate and pyruvate (ldh-1) was confined to
point mutants, consistent with our biochemical data, which showed
high lactate levels only in the Arg244His point mutants. Together,
the data suggest that Arg244His point mutants, which develop into
sterile adults, exhibit a higher glycolytic activity alongside a
partially functioning TCA cycle, where the glyoxylate shunt likely
compensates for the absence of SDH activity. However, null
mutants (which show arrested development at the L2 larval stage)
Fig. 8. Arg244His point mutants exhibit a rewired metabolism compared to sdhb-1(gk165) null mutants. icl-1(RNAi) and LDH-1 inhibitor further
enhance the premature developmental arrest of gk165 deletional and R244H point mutants, respectively. (A,B) Amodel representing metabolic changes in sdhb-
1(gk165) null mutants (A) and Arg244His point mutants (B). Both mutants display elevated glyoxylate cycle activity. Only point mutants partially use their TCA
cycle while exhibiting high glycolytic activity. Expression of the genes encoding enzymes labeled in blue was analyzed by qPCR. Red arrows indicate high
expression; black arrows indicate normal expression. (C,D) icl-1(RNAi) treatment affected gk165 null mutants selectively: (C) embryonic lethality occurred in
42.5% of treated gk165 homozygotes (n=353), whereas gk165 animals fed HT115 bacteria expressing empty vector pPD129.36 (control RNAi) showed
embryonic lethality in only 19.9% of the cases (n=315). (D) Lifespan of null mutant (n=188) and point mutant (n=155) animals was measured after ingestion
of dsRNA specific for icl-1. Only null sdhb-1(gk165) animals showed a significantly shorter survival compared to their respective controls sdhb-1(gk165);
control RNAi (n=148) and R244H;control RNAi (n=155) (n=3 separate experiments). (E) R244H mutants were treated by LDH-A inhibitor GSK2837808A at
1 µM and 10 µM concentrations. The compound had no effect at the lower concentration, but at 10 µM 12.4% of treated animals demonstrated increased
L2/L3 larval arrest. Statistical significance is indicated in each graph as ***P≤0.001, **P≤0.01 and *P≤0.05 versus the corresponding sample (NS, not
significant). Results of embryonic lethality and LDH-A inhibitor treatment were analyzed by one-way ANOVA. Lifespan measurement was analyzed by
independent two-sample Student's t-test with Bonferroni correction. Error bars represent s.e.
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have no similarly rewired metabolism and can only use the
glyoxylate cycle, which might explain their early arrested
development. In this respect, in Arg244His mutants, the
glycolytic-oxphos metabolite concentrations/ratios were
reminiscent of tumor cells undergoing Warburg effect, i.e.
favoring glycolysis even under aerobic conditions instead of
oxidative phosphorylation (Vander Heiden et al., 2009).
Consistent with this notion, the Warburg effect was shown to be
induced in human hepatocellular carcinoma cells in response to
decreased succinate dehydrogenase B activity (Tseng et al., 2018).
In the work reported here, we have generated a novel nematode
model for examining and evaluating the developmental and metabolic
consequences of two clinically important SDHB mutations (null and
point mutant). We observed very different metabolic alterations as a
result of sdhb-1 deletion in comparison to an equally cancer-proven
but highly malignant (Arg230His) missense mutation.
We propose that such a worm model could, in principle, be used
to test the effect of different drug candidates to see whether they act
selectively on mutant worms, leaving both normal and null worms
unscathed. In a pilot experiment, we targeted the glyoxylate shunt
and lactate metabolism in our model. In order to attenuate the
glyoxylate shunt, we inactivated, by RNAi, icl-1, which encodes
isocitrate lyase, the key enzyme of the shunt. We found that
icl-1(RNAi) treatment selectively acted on gk165 null mutants,
caused a partially penetrant embryonic lethality and shortened
lifespan. These data are consistent with the idea that the glyoxylate
cycle serves a critical role in null mutants by sustaining their
development until the L2 stage. However, R244H point mutants,
which are able to reach adulthood, specifically display an elevated
lactate dehydrogenase (ldh-1) expression in addition to the
increased icl-1 message. We tested the notion that these point
mutated animals use lactate as an energy source as a consequence of
an increased LDH-1 production, by pharmacologically inhibiting
LDH-1 activity using an established LDH-A inhibitor previously
studied in human cells. LDH-1 inhibition resulted in an earlier than
expected L2/L3 larval arrest of point mutants, showing that LDH-1
activity is indeed crucial in their development.
Thus, we have shown that our novel PPGL model is potentially
druggable. Our modeling approach might also be of benefit to
research groups studying other SDH mutations and different TCA
cycle genes linked to metabolic diseases and cancer.
During the preparation of this paper, Lotti et al. (2019) extended
the tripartite classification of PPGL (see Introduction) using a
developmentally based approach to PPGL ontogeny. They examined
the morphology of PPGL and propose that ‘paraganglioma is a
fundamentally organized, albeit aberrant, tissue composed of
neoplastic vascular and neural cell types that share a common
origin from a multipotent mesenchymal-like stem/progenitor cell’
(Lotti et al., 2019). Our developmental paradigm provides a tractable
model to test this idea and the classical classification system using
tractable (and potentially druggable) C. elegans.
MATERIALS AND METHODS
C. elegans strains
C. elegans strains were maintained under standard conditions (Brenner,
1974). The following strains were used: wild type (WT), Bristol N2; VC294,
{sdhb-1(gk165)/ mIn1 (mIs14 [myo-2::gfp; pes-10::gfp]) dpy-10(e128)]
II.}; COP952, [pNU636 (Psdhb-1_sdhb-1(genomic G731A)_UTRsdhb-1;
unc-119(+)) X.; unc-119(ed3) III.]; COP957, [pNU637 (Psdhb-1_sdhb-
1(genomic wt)_UTRsdhb-1; unc-119(+)) X.; unc-119(ed3) III.]; R244H,
sdhb-1(gk165)/ mIn1 [mIs14 [myo-2::gfp; pes-10::gfp] dpy-10(e128)] II.;
unc-119(ed3) III.(?); pNU636 (Psdhb-1_sdhb-1(G731A)_UTRsdhb-1; unc-
119(+)) X.; WTR, sdhb-1(gk165)/ sdhb-1(gk165) II.; unc-119(ed3) III.(?);
pNU637 (Psdhb-1_sdhb-1(genomic wt)_UTRsdhb-1; unc-119(+)) X.; sdhb-
1p::gfp reporter strain, unc-119(ed3)III; Ex[psdhb-1::gfp + unc-119(+)].
Genotyping of mutant strains
For genotyping the gk165 deletion, we used the following forward and
reverse primers: 5′-TGAAATTGCATTGTCCTCTCAC-3′ and 5′-
CGATTTGATCTCTCCGATGG-3′ (Table S12). In this study, we also
used two transgenic strains generated by Knudra Transgene Service: sdhb-1
wild-type transgenic strain [sdhb-1p::SDHB-1(wt)::sdhb-1u] and a
transgenic strain carrying the Arg244His missense mutation (caused by a
G731A point mutation in the coding sequence) [sdhb-1p::SDHB-
1(G731A)::sdhb-1u]. Both strains carry the corresponding single-copy
transgene inserted into a given region of the X chromosome byMosSCI. For
genotyping the transgenes, we used the following primers: F1, 5′-GATC-
AAATCGCTGCTTACTG-3′; F2, 5′-CATTTGATCAGCGTAGTTGC-3′;
R1, 5′-ATTCTTTCTCCTAGCCTTCG-3′ (Table S12). F1+R1 amplifies a
770 bp transgene-specific product (the product from the wild type is too
large to be amplified), while amplification by F2+R1 gives a 460 bp
wild-type-specific product.
Lifespan assay
Lifespan assays were conducted at 20°C on nematode growth medium
(NGM) plates seeded with Escherichia coli [OP50 or HT115(DE3)]
bacteria. The worms were synchronized by NaOH/hypochlorite treatment.
Three to four parallel plates with 40 animals of the corresponding strains
were used. The numbers of animals used for the experiment are shown
(Table S1). Animals that climbed up the wall of plastic dishes or died
prematurely because of picking were excluded/censored from the analysis.
Animals were scored as dead when they no longer moved when pushed a
few times. IBM SPSS Statistics software was used to carry out statistical
analysis. The P-values for comparing Kaplan–Meyer survival curves
between two groups were determined using log-rank tests. The P-values for
comparing mean lifespans were determined using independent two-sample
Student’s t-tests with Bonferroni correction.
Wes
Protein lysates of worms of different genotypes were prepared as described
in Farkas et al. (2019). The protein content of worm lysates was quantified
by Bradford protein assay (Bio-Rad) and immunodetected with Wes Simple
analysis on Wes system (ProteinSimple-Biotechne 004-600). Then,
12-230 kDa Separation Module (ProteinSimple SM-W004) and an Anti-
Rabbit Detection Module (ProteinSimple DM-001) were applied. Briefly,
protein samples were diluted in sample buffer thereafter mixed with
Fluorescent Master Mix 1:4 and denatured at 95°C for 5 min. According to
the manufacturer’s instructions, the samples, blocking reagent (antibody
diluent), primary antibodies, horseradish peroxidase (HRP)-conjugated
secondary antibodies and chemiluminescent substrate were added to the
plate. Immunodetection was performed automatically, and the results are
reported as virtual gels based on chemiluminescence signals. The default
settings of the device were the following: stacking and separation at 375 V
for 25 min; blocking reagent for 30 min; primary and secondary antibodies
both for 30 min; luminol/peroxide chemiluminescence detection for 30 min
(exposure times were selected for the antibodies between 1 s and 512 s). The
following primary antibodies were used: rabbit polyclonal anti-DYN-1
(1:100; kindly provided by Zheng Zhou, Baylor College of Medicine,
Houston, TX, USA, rabbit anti-SDHB (1:50; GTX104628, Genetex).
Generation of a transgenic strain
The sdhb-1 minimal promoter fragment was amplified using primers listed
in Table S12 and was digested with AscI and NotI, then cloned into pRH21
(Hofmann et al., 2002). Subsequently, transgenic worms were generated by
biolistic transformation using the unc-119(ed3) mutant genetic background
and the unc-119(+) gene as a co-transformation marker.
LC-MS
Worms at different larval stages were picked to Eppendorf tubes containing
M9 solution (in order to prevent any effect of E. coli metabolites on the
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measurements). Samples were centrifuged at 15,294 g at 4°C for 3 min, after
which the supernatant was discarded and the pellet was placed to liquid
nitrogen until it became frozen. Metabolite extraction was performed by
adding 450 μl methanol:chloroform:water (9:1:1 v/v) solution to the pellets,
which were then homogenized and vortexed for a minute. Next, the pellet
was centrifuged at 20,817 g at 4°C for 10 min. The supernatant was
transferred to a new Eppendorf tube and was stored at −80°C until
measurement was performed. LC-MS/MS assays were conducted using a
Perkin-Elmer Flexar FX10 ultra-performance liquid chromatograph coupled
with a Sciex 5500 QTRAP mass spectrometer. For chromatographic
separation, a Phenomenex Luna Omega C18 column (100×2.1 mm, 1.6 µm)
was used (Gen-Lab Ltd, Budapest, Hungary). The mobile phase consisted of
water containing 0.1% (v/v) formic acid (A) and methanol containing 0.1%
(v/v) formic acid (B). The following gradient program was used: 100% A,
hold 0.2 min, ramp A to 10% in 9.8 min, immediately ramp A back to 100%
in 1.0 min, hold 7.0 min. The total run time was 18.0 min, the flow rate was
180 µl/min and 5 µl sample was injected. Column temperature was set at
35°C. The mass spectrometer was set to negative electrospray ionization
mode using the following parameters: source temperature, 300°C; ionization
voltage, −4000 V; curtain gas, 35 psi; gas1, 35 psi; gas2, 35 psi; entrance
potential, −10 V; CAD gas, medium.
Quantitative analysis was performed in multiple reaction monitoring
(MRM) mode. The following metabolites were detected: citrate, fumarate,
lactate, malate, pyruvate, succinate, aspartate, glutamate. IBM SPSS
Statistics software was used to carry out statistical analysis and determine
means±s.d. using one-way ANOVA.
Oxygen consumption measurement by Seahorse XF Analyzer
The Seahorse XF96 Analyzer (Agilent, USA) was used for assessment of
worm bioenergetics. Hydration of probes was performed with 200 µl
Seahorse Bioscience XF96 calibrant (pH 7.4) solution at 37°C overnight.
Heat and temperature control on the Seahorse XF96 Analyzer was switched
off and the experiment was carried out in a cold room of 10°C in order to
ensure a temperature of 20°C inside the analyzer. Worms were picked into
M9-filled 96-well Seahorse plates (L4 larval stage, 20 worms per well; L2
larval stage, 100 worms per well).We used two compounds, FCCP at 10 µM
final well concentration and sodium azide at 40 mM final well concentration,
to assess bioenergetics in sdhb-1mutant worms and control strains. FCCP is a
protonophore and uncoupler reagent of mitochondrial oxidative
phosphorylation, which uncouples ATP synthesis (phosphorylation) from
the electron transport chain (oxidation) by transporting H+ ions through the
mitochondrial membrane bypassing the ATP synthase. Sodium azide is a
complex IV (cytochrome c oxidase) inhibitor, which binds directly to the
heme prosthetic group of cytochrome c oxidase to prevent the final transfer of
electrons to oxygen. It also inhibits the reverse mode of ATP synthase. First,
the total cellular OCR was measured, from which basal respiration can be
derived by subtracting non-mitochondrial oxygene consumption. In our
experiments, 100 μM FCCP was injected to obtain maximal respiration, then
400 mM sodium azide was used to allow measurements of the non-
mitochondrial respiration. Spare capacity was calculated based on the
difference between the basal respiration and maximal respiration. IBM SPSS
Statistics software was used to carry out statistical analysis and determine
means±s.d. using one-way ANOVA.
Mitotracker
A synchronized population of worms was obtained after embryo isolation, then
washed three times with M9 buffer. The worms were incubated with the
Mitotracker dye (MitotrackerRedCMXRos, Sigma-Aldrich) for 30 min at 22°C,
then washed three times with M9 buffer. Randomly selected worms were
observed under confocal microscopy at 40× after being paralyzed with 2%
sodium azide solution. This techniquemeasures the relative fold-change intensity
of mitochondrial content. IBM SPSS Statistics software was used to carry out
statistical analysis and determine means±s.d. using two-sample Student’s t-tests.
ATP assay
After obtaining a synchronized population of worms, 2000 worms from
each group (obtained by normalized approximation procedure for worm
number) were homogenized in a sonicator and the supernatant was
collected. A Bradford assay was performed to estimate the protein content
in the supernatant. For each group, 20 μg of the protein was collected, to
which 200 μl of ATP assay mix was added. The luminescence was
immediately read using a Perkin Elmer (Victor) luminometer. IBM SPSS
Statistics software was used to carry out statistical analysis and determine
means±s.d. using two-sample Student’s t-tests.
Modeling the human SDHA/B complex
The multiple alignment was generated using P21912|SDHB_HUMAN
Succinate dehydrogenase B as query to perform a blastp search using the
BLAST tools of NCBI. Top-matching sequences, annotated as succinate
dehydrogenase B, were selected and were aligned with the Constraint-based
Multiple Alignment Tool of NCBI (Fig. 6A). Subunits A and B of porcine
SDH (PDB ID: 4YTP) were used to model human SDHA/B complex (97%
sequence identity to human SDHA/B; see Fig. S5 for alignment). Transit
sequences were omitted in the modeling process. The wild-type and R230H
variants of human SDHA/B complex were constructed using homology
modeling. Modeller (Sali and Blundell, 1993) was employed to generate
1000 homology models for each of the wild-type and R230H mutant.
Twenty models were selected from the 1000 models: the top ten models
selected by the DOPE scoring function (Shen and Sali, 2006) and the top ten
models selected by Modeller’s probability density function. Inter-residue
pairwise contacts were calculated using an in-house Python implementation.
Two residues were deemed to be in contact if any two heavy atoms from the
two residues were less than 4.5 Å apart. Averaged contact frequency was
evaluated by averaging the corresponding residue-pair contacts over the 20
models. Differences in averaged residue-pair contact frequencies were used
to quantify the structural changes upon mutation.
Transcriptomics analysis
RNA sequencing (RNA-seq)
The total nucleic acid extraction of wild-type and mutant animals was
conducted by TRI Reagent® (Molecular Research Center, Cincinnati, OH,
USA) as recommended by the manufacturer. The crude extract was further
purified with RNeasy Mini Kit (Qiagen, Hilden, Germany) using the
manufacturer’s protocol. To remove DNA contamination that might
interfere with downstream applications, Column DNase treatment with
Qiagen RNase-free DNase kit was applied. To purify pure mature polyA-
tailed mRNA, we performed a magnetic bead-based separation on the
purified total RNA with NEB NEXT Poly(A) mRNA magnetic Isolation
Module (New England Biolabs, Ipswich, MA, USA). We used 100 ng
mature polyA-tailed mRNA per sample to construct RNA-seq libraries. The
NEB NEXT ULTRA II Directional RNA Library Preparation Kit (Illumina,
San Diego, CA, USA) was used to create sample libraries using the NEB
factory protocol. Each sample was individually indexed with NEB NEXT
Multiplex Oligos for the Illumina Kit. Samples were equimolarly pooled to a
4 nM sequencing library and sequenced with Illumina MiSEQ v2 500
cycles reagent on the Illumina MiSEQ System.
The C. elegans WBcel235 genome release 94 assemblies were obtained
from the Ensembl database. The chromosomal sequences and annotation
files were downloaded as FASTA and GTF format, respectively. Genome
and transcriptome sequences in FASTA format were indexed with Tophat2
(Bowtie2). Illumina paired-end sequencing data were exported in FASTQ
file format.
The FASTQC program (https://www.bioinformatics.babraham.ac.uk/
projects/fastqc/) was used to pre-process RNA-seq data, to evaluate the
qualities of original and trimmed reads (Martin, 2011). The trimmed
sequence sets were aligned to the genome with Tophat2 (Bowtie2), using
default parameters (Langmead et al., 2009; Kim et al., 2013). For further
analysis, the reads were sorted by Samtools (http://samtools.sourceforge.
net) according to coordinates. The function feature counts (Rsubread
R package) were used for counting reads to genomic features. Two variants
of count-based gene expression level estimation union-exon and transcript-
based counting were used. To implement union-exon, we selected the exon
entries from the annotation files, grouped them by the Ensembl gene
identifier, and merged overlapping exons for each gene using the function to
summarize overlaps from bioconductor library GenomicAlignments. We
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then generated per-gene counts by intersecting the genomic alignments with
the resulting ‘pseudoexons’ using featureCount (Liao et al., 2014).
The Bioconductor package edgeR was used for differential expression
analyses of read counts for genomic features arising from RNA-seq
(Robinson et al., 2010; McCarthy et al., 2012). IBM SPSS Statistics
software was used to carry out statistical analysis and determine means±s.d.
using two-sample Student’s t-tests with Bonferroni correction.
Transcriptomics validation
For validation of the gene expression data calculated in the transcriptomic
analysis a reverse transcription (RT)-qPCR approach was used. Primers
were designed for candidate genes [cdc-42 (reference gene), aco-2, fum-1,
gdh-1, icl-1, idh-2, ldh-1, men-1, pck-2, pyc-1, sdha-1] on exon boundaries
suitable for SYBR GREEN assay using Primer3 (Table S12). Primers were
manufactured by Eurofins Genomics AT GmbH. RNA was prepared as
described above and 100 ng was transcribed to cDNAwith a High-Capacity
RNA-to-cDNA Kit (Thermo Fisher Scientific, Waltham, MA, USA).
cDNA was assayed with a SensiFAST SYBR Lo-ROX Kit (Bioline,
London, UK) and using specific primers spanning exon boundaries of
respective genes on a Quant Studio 7 FLEX Q-RT-PCR system (Thermo
Fisher Scientific). Relative gene expression was estimated by the ddCt
method (Pfaffl, 2004). IBM SPSS Statistics software was used to carry out
statistical analysis and determine means±s.d. using one-way ANOVA.
RNAi
The icl-1(gei-7) PCR fragment was amplified using primers listed in
Table S12. Next, it was cloned into L4440 vector (pPD129.36; Fire Lab
1997 Vector Kit) by SacI and Acc65I. The obtained construct was
transformed into bacterial strain HT115(DE3). RNAi experiments were
performed at 20°C as described (Timmons, 2006).
LDH-A inhibitor treatment
R244H animals were treated by LDH-A inhibitor GSK2837808A (Tocris) at
1 µM and 10 µM (Xie et al., 2014). R244H strain was synchronized by
NaOH/hypochlorite treatment, and embryos were put on NGM plates with a
seeded lawn of OP50 bacteria containing GSK2837808A at a final
concentration of 1 µM and 10 µM.
Consent to participate
For the family tree mentioned in this article, we contacted members
of the family through Findacure Foundation and the Phaeo Para
Cancer Charity. They provided consent and their phenotypic data.
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